Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

CytRx Corporation Remains An Undiscovered Opportunity In The Cancer Space
Seeking Alpha
Wednesday, September 18, 2013 - 10:21am
tags:
CytRx, cancer
Chantix Does Not Increase Depression Risk? A Pfizer Study Says Yes
Pharmalot
Wednesday, September 18, 2013 - 10:15am
tags:
Chantix, Pfizer, depression, smoking cessation
What's MannKind Really Worth?
Motley Fool
Wednesday, September 18, 2013 - 8:51am
tags:
MannKind, Afrezza, diabetes
Teva: A Frustrating Company
Seeking Alpha
Wednesday, September 18, 2013 - 8:48am
tags:
Teva
Analysis: Bribery scandal dents Big Pharma sales in China, GSK hardest hit
Yahoo/Reuters
Wednesday, September 18, 2013 - 8:48am
tags:
China, GSK
AstraZeneca says FDA accepts application for Epanova
The Fly on the Wall
Wednesday, September 18, 2013 - 8:46am
tags:
AstraZeneca, FDA, Epanova, hypertriglyceridemia
IPO Preview: Five Prime Therapeutics
Seeking Alpha
Tuesday, September 17, 2013 - 6:06pm
tags:
IPOs, Five Prime
Clovis Oncology Said to Explore Sale of Biotech Company
Bloomberg
Tuesday, September 17, 2013 - 4:37pm
tags:
Clovis Oncology, M&A
Aging population to fuel big leap in cancer cases--and drug sales
Fierce Pharma
Tuesday, September 17, 2013 - 12:36pm
tags:
cancer, aging, Roche, Celgene, GSK, Novartis, Pfizer, Bayer
Dendreon jumps on winning European approval for prostate-cancer treatment
Marketwatch
Tuesday, September 17, 2013 - 12:34pm
tags:
Europe, prostate cancer, Dendreon, Provenge
KV Pharmaceutical Company Completes Reorganization And Successfully Emerges From Chapter 11 With $375 Million Recapitalization
Marketwatch
Tuesday, September 17, 2013 - 12:26pm
tags:
KV Pharmaceutical, bankruptcy, reorganization
[video]Patent Expirations AbbVie Investors Need to Watch
Motley Fool
Tuesday, September 17, 2013 - 11:49am
tags:
AbbVie, Humira, patents, patent expirations
Will the Exelixis Hype Catch Up to Its Valuation?
Motley Fool
Tuesday, September 17, 2013 - 11:04am
tags:
Exelixis, Cometriq, medullary thyroid cancer
Arthrex asks Supreme Court to hear appeal in $85M loss to Smith & Nephew
Mass Device
Tuesday, September 17, 2013 - 10:53am
tags:
Supreme Court, Smith & Nephew, Arthrex, devices, patents
Biotechs keep the cash pumping (for now) with more IPOs and ATMs
Fierce Biotech
Tuesday, September 17, 2013 - 10:01am
tags:
IPOs, Fate Therapeutics, biotech, ATMs
Agenus reports positive follow-on Phase 2 brain cancer vaccine results
Yahoo/Fly on the Wall
Tuesday, September 17, 2013 - 9:57am
tags:
Agenus, brain cancer, vaccine, glioblastoma multiforme, Prophage Series G-100
Verastem: An Attractive Long-Term Investment In The Cancer Stem Cell Space
Seeking Alpha
Tuesday, September 17, 2013 - 9:54am
tags:
stem cells, cancer, Verastem, VS-4718, Defactinib, VS-5584
New Patents for Insmed's Arikace
Yahoo/Zacks
Tuesday, September 17, 2013 - 9:50am
tags:
patents, Insmed, Arikace
Sanofi wins EU approval for second MS treatment
Reuters
Tuesday, September 17, 2013 - 9:46am
tags:
Sanofi, Europe, MS, multiple sclerosis, Aubagio, Lemtrada
Ranbaxy Ratings Cut After FDA Restricts Imports to U.S.
Bloomberg
Tuesday, September 17, 2013 - 9:45am
tags:
FDA, Ranbaxy

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.